These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30386198)

  • 1. Secondary Adrenal Insufficiency after Treatment with Budesonide for Autoimmune Hepatitis.
    De Maeyer F; Lapauw B; Hoorens A; Geerts A; Van Vlierberghe H; Verhelst X
    Case Rep Gastroenterol; 2018; 12(3):597-601. PubMed ID: 30386198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies for autoimmune hepatitis.
    Manns MP; Strassburg CP
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune hepatitis-standard and second-line therapy].
    Taubert R; Jaeckel E
    Internist (Berl); 2018 Jun; 59(6):536-543. PubMed ID: 29725696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIH: Which Alternative for Difficult-to-Treat Patients?
    Sebode M; Schramm C
    Dig Dis; 2015; 33 Suppl 2():83-7. PubMed ID: 26641096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide for the treatment of autoimmune hepatitis.
    Snider KR; Potter TG
    Ann Pharmacother; 2011 Sep; 45(9):1144-50. PubMed ID: 21878659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.
    Geier A; Gartung C; Dietrich CG; Wasmuth HE; Reinartz P; Matern S
    World J Gastroenterol; 2003 Dec; 9(12):2681-5. PubMed ID: 14669312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis.
    Peiseler M; Liebscher T; Sebode M; Zenouzi R; Hartl J; Ehlken H; Pannicke N; Weiler-Normann C; Lohse AW; Schramm C
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):260-267.e1. PubMed ID: 28126427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
    Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
    J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide induces complete remission in autoimmune hepatitis.
    Csepregi A; Röcken C; Treiber G; Malfertheiner P
    World J Gastroenterol; 2006 Mar; 12(9):1362-6. PubMed ID: 16552802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in the diagnosis and management of autoimmune hepatitis.
    Kriese S; Heneghan MA
    Frontline Gastroenterol; 2013 Jan; 4(1):2-11. PubMed ID: 28839695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral budesonide for treatment of autoimmune chronic active hepatitis.
    Danielsson A; Prytz H
    Aliment Pharmacol Ther; 1994 Dec; 8(6):585-90. PubMed ID: 7696446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
    Manns MP; Woynarowski M; Kreisel W; Lurie Y; Rust C; Zuckerman E; Bahr MJ; Günther R; Hultcrantz RW; Spengler U; Lohse AW; Szalay F; Färkkilä M; Pröls M; Strassburg CP;
    Gastroenterology; 2010 Oct; 139(4):1198-206. PubMed ID: 20600032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide in previously untreated autoimmune hepatitis.
    Wiegand J; Schüler A; Kanzler S; Lohse A; Beuers U; Kreisel W; Spengler U; Koletzko S; Jansen PL; Hochhaus G; Möllmann HW; Pröls M; Manns MP
    Liver Int; 2005 Oct; 25(5):927-34. PubMed ID: 16162148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
    Rizvi S; Gawrieh S
    Drugs Aging; 2018 Jul; 35(7):589-602. PubMed ID: 29971609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
    Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
    J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and therapy of autoimmune hepatitis.
    Granito A; Muratori P; Ferri S; Pappas G; Quarneti C; Lenzi M; Bianchi FB; Muratori L
    Mini Rev Med Chem; 2009 Jun; 9(7):847-60. PubMed ID: 19519509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and prospective pharmacotherapy for autoimmune hepatitis.
    Czaja AJ
    Expert Opin Pharmacother; 2014 Aug; 15(12):1715-36. PubMed ID: 24961409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune hepatitis and overlap syndrome: therapy].
    Löhr HF
    Praxis (Bern 1994); 2002 Aug; 91(34):1347-51. PubMed ID: 12233265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.